1011 related articles for article (PubMed ID: 21240262)
1. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
[TBL] [Abstract][Full Text] [Related]
2. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Yan X; Tang B; Chen B; Shan Y; Yang H;
Elife; 2019 Mar; 8():. PubMed ID: 30860027
[TBL] [Abstract][Full Text] [Related]
3. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
Shi Y; Liu C; Liu X; Tang DG; Wang J
PLoS One; 2014; 9(3):e90022. PubMed ID: 24595209
[TBL] [Abstract][Full Text] [Related]
4. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
5. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
7. miRNA-708 control of CD44(+) prostate cancer-initiating cells.
Saini S; Majid S; Shahryari V; Arora S; Yamamura S; Chang I; Zaman MS; Deng G; Tanaka Y; Dahiya R
Cancer Res; 2012 Jul; 72(14):3618-30. PubMed ID: 22552290
[TBL] [Abstract][Full Text] [Related]
8. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Li J; Lam M;
Elife; 2015 Jul; 4():e06434. PubMed ID: 26231042
[TBL] [Abstract][Full Text] [Related]
9. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.
Yu G; Li H; Wang J; Gumireddy K; Li A; Yao W; Tang K; Xiao W; Hu J; Xiao H; Lang B; Ye Z; Huang Q; Xu H
J Urol; 2014 Oct; 192(4):1229-37. PubMed ID: 24866595
[TBL] [Abstract][Full Text] [Related]
10. NUMB suppression by miR-9-5P enhances CD44
Wang X; Cai J; Zhao L; Zhang D; Xu G; Hu J; Zhang T; Jin M
Sci Rep; 2021 May; 11(1):11210. PubMed ID: 34045601
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
Zuo J; Zhu K; Wang Y; Yu Z
Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma.
Sun D; Wu Y; Zhang S; Han Y; Shen J; Zheng W; Wei L; Liu Y; Ren L; Gu Z; Liu Y; Liu S; Ding C
Biomed Pharmacother; 2021 Oct; 142():111967. PubMed ID: 34467896
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
[No Abstract] [Full Text] [Related]
14. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression.
Fan X; Chen X; Deng W; Zhong G; Cai Q; Lin T
BMC Cancer; 2013 Feb; 13():61. PubMed ID: 23383988
[TBL] [Abstract][Full Text] [Related]
16. Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.
Lin L; Jiang H; Huang M; Hou X; Sun X; Jiang X; Dong X; Sun X; Zhou B; Qiao H
Oncol Rep; 2015 Aug; 34(2):663-72. PubMed ID: 26035691
[TBL] [Abstract][Full Text] [Related]
17. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
18. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.
Chen WY; Liu SY; Chang YS; Yin JJ; Yeh HL; Mouhieddine TH; Hadadeh O; Abou-Kheir W; Liu YN
Oncotarget; 2015 Jan; 6(1):441-57. PubMed ID: 25436980
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
